Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV Treatment Adherence Survey
While a majority of people with HIV worldwide achieve an undetectable viral load, it may not be durable over time.
Here’s what you need to know to share the news on World AIDS Day—and beyond!
NoiseFilter’s latest animated HIV series explains U=U, PrEP and PEP—with help from trans activist Milan Nicole Sherry.
Study shows just one snapshot of the impact of COVID-19 on the health and access to care among people living with HIV.
The health and prevention benefits of an undetectable viral load may be uniquely important in the American health care system.
Compared to other common HIV treatments, dolutegravir-based regimens maintained viral suppression even without perfect adherence.
In stressing U=U, New Jersey’s acting attorney general wants to ensure that no one living with HIV is charged unjustly.
People in JumpstART achieved viral suppression three times faster than those in the control group.
Despite being disproportionately affected by HIV, many Latinos living with the virus are thriving.
People 55 and older make up 37% of the U.S. HIV population. Most are undetectable. What’s more, PrEP use increased among this age group.
These encouraging results do not apply, however, to people who remain undiagnosed.
If at first you don’t reach an undetectable viral load, try, try again.
A low-barrier HIV care program with access to multiple services in one place can help.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.